Click for best price
Assisted Reproductive Technologies Medications Market Size, Share 2023
The global Assisted Reproductive Technologies Medications market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Assisted reproductive technology?(ART) is used to treat infertility. It includes fertility treatments that handle both eggs and sperm. A number of different agents are used to achieve controlled ovarian hyperstimulation. These include clomiphene, GnRH analogues, menotropins, urofollitropin, highly purified FSH, and recombinant human FSH (rh-FSH), etc.
This report aims to provide a comprehensive presentation of the global market for Assisted Reproductive Technologies Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Assisted Reproductive Technologies Medications. This report contains market size and forecasts of Assisted Reproductive Technologies Medications in global, including the following market information:
- Global Assisted Reproductive Technologies Medications Market Revenue, 2018-2023, 2024-2032, ($ millions)
- Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Down-Regulation Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Assisted Reproductive Technologies Medications include Merck, MSD, Ipsen, Ferring, Organon, Solvay, Besins, Zhejiang Xianju and Changchun GeneScience, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Assisted Reproductive Technologies Medications companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Assisted Reproductive Technologies Medications Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Assisted Reproductive Technologies Medications Market Segment Percentages, by Type, 2022 (%)
- Down-Regulation Drugs
- Ovulation Stimulation Drugs
- Ovulation Inducing Drugs
- Luteal Support Medications
Global Assisted Reproductive Technologies Medications Market, by Channel, 2018-2023, 2024-2032 ($ millions)
Global Assisted Reproductive Technologies Medications Market Segment Percentages, by Channel, 2022 (%)
- Hospital Pharmacy
- Specialty & Retail Pharmacy
- Online Pharmacy
Global Assisted Reproductive Technologies Medications Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Assisted Reproductive Technologies Medications Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Assisted Reproductive Technologies Medications revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Assisted Reproductive Technologies Medications revenues share in global market, 2022 (%)
Key players include:
- Merck
- MSD
- Ipsen
- Ferring
- Organon
- Solvay
- Besins
- Zhejiang Xianju
- Changchun GeneScience
- Hybio Pharmaceutical
- Livzon Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Assisted Reproductive Technologies Medications, market overview.
Chapter 2: Global Assisted Reproductive Technologies Medications market size in revenue.
Chapter 3: Detailed analysis of Assisted Reproductive Technologies Medications company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Assisted Reproductive Technologies Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Assisted Reproductive Technologies Medications Market, Global Outlook and Forecast 2023-2032 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
67 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Assisted Reproductive Technologies Medications Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Channel
1.3 Global Assisted Reproductive Technologies Medications Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Assisted Reproductive Technologies Medications Overall Market Size
2.1 Global Assisted Reproductive Technologies Medications Market Size: 2022 VS 2032
2.2 Global Assisted Reproductive Technologies Medications Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Assisted Reproductive Technologies Medications Players in Global Market
3.2 Top Global Assisted Reproductive Technologies Medications Companies Ranked by Revenue
3.3 Global Assisted Reproductive Technologies Medications Revenue by Companies
3.4 Top 3 and Top 5 Assisted Reproductive Technologies Medications Companies in Global Market, by Revenue in 2022
3.5 Global Companies Assisted Reproductive Technologies Medications Product Type
3.6 Tier 1, Tier 2 and Tier 3 Assisted Reproductive Technologies Medications Players in Global Market
3.6.1 List of Global Tier 1 Assisted Reproductive Technologies Medications Companies
3.6.2 List of Global Tier 2 and Tier 3 Assisted Reproductive Technologies Medications Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Assisted Reproductive Technologies Medications Market Size Markets, 2022 & 2032
4.1.2 Down-Regulation Drugs
4.1.3 Ovulation Stimulation Drugs
4.1.4 Ovulation Inducing Drugs
4.1.5 Luteal Support Medications
4.2 By Type - Global Assisted Reproductive Technologies Medications Revenue & Forecasts
4.2.1 By Type - Global Assisted Reproductive Technologies Medications Revenue, 2018-2023
4.2.2 By Type - Global Assisted Reproductive Technologies Medications Revenue, 2024-2032
4.2.3 By Type - Global Assisted Reproductive Technologies Medications Revenue Market Share, 2018-2032
5 Sights by Channel
5.1 Overview
5.1.1 By Channel - Global Assisted Reproductive Technologies Medications Market Size, 2022 & 2032
5.1.2 Hospital Pharmacy
5.1.3 Specialty & Retail Pharmacy
5.1.4 Online Pharmacy
5.2 By Channel - Global Assisted Reproductive Technologies Medications Revenue & Forecasts
5.2.1 By Channel - Global Assisted Reproductive Technologies Medications Revenue, 2018-2023
5.2.2 By Channel - Global Assisted Reproductive Technologies Medications Revenue, 2024-2032
5.2.3 By Channel - Global Assisted Reproductive Technologies Medications Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Assisted Reproductive Technologies Medications Market Size, 2022 & 2032
6.2 By Region - Global Assisted Reproductive Technologies Medications Revenue & Forecasts
6.2.1 By Region - Global Assisted Reproductive Technologies Medications Revenue, 2018-2023
6.2.2 By Region - Global Assisted Reproductive Technologies Medications Revenue, 2024-2032
6.2.3 By Region - Global Assisted Reproductive Technologies Medications Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Assisted Reproductive Technologies Medications Revenue, 2018-2032
6.3.2 US Assisted Reproductive Technologies Medications Market Size, 2018-2032
6.3.3 Canada Assisted Reproductive Technologies Medications Market Size, 2018-2032
6.3.4 Mexico Assisted Reproductive Technologies Medications Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Assisted Reproductive Technologies Medications Revenue, 2018-2032
6.4.2 Germany Assisted Reproductive Technologies Medications Market Size, 2018-2032
6.4.3 France Assisted Reproductive Technologies Medications Market Size, 2018-2032
6.4.4 U.K. Assisted Reproductive Technologies Medications Market Size, 2018-2032
6.4.5 Italy Assisted Reproductive Technologies Medications Market Size, 2018-2032
6.4.6 Russia Assisted Reproductive Technologies Medications Market Size, 2018-2032
6.4.7 Nordic Countries Assisted Reproductive Technologies Medications Market Size, 2018-2032
6.4.8 Benelux Assisted Reproductive Technologies Medications Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Assisted Reproductive Technologies Medications Revenue, 2018-2032
6.5.2 China Assisted Reproductive Technologies Medications Market Size, 2018-2032
6.5.3 Japan Assisted Reproductive Technologies Medications Market Size, 2018-2032
6.5.4 South Korea Assisted Reproductive Technologies Medications Market Size, 2018-2032
6.5.5 Southeast Asia Assisted Reproductive Technologies Medications Market Size, 2018-2032
6.5.6 India Assisted Reproductive Technologies Medications Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Assisted Reproductive Technologies Medications Revenue, 2018-2032
6.6.2 Brazil Assisted Reproductive Technologies Medications Market Size, 2018-2032
6.6.3 Argentina Assisted Reproductive Technologies Medications Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Assisted Reproductive Technologies Medications Revenue, 2018-2032
6.7.2 Turkey Assisted Reproductive Technologies Medications Market Size, 2018-2032
6.7.3 Israel Assisted Reproductive Technologies Medications Market Size, 2018-2032
6.7.4 Saudi Arabia Assisted Reproductive Technologies Medications Market Size, 2018-2032
6.7.5 UAE Assisted Reproductive Technologies Medications Market Size, 2018-2032
7 Assisted Reproductive Technologies Medications Companies Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Assisted Reproductive Technologies Medications Major Product Offerings
7.1.4 Merck Assisted Reproductive Technologies Medications Revenue in Global Market (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 MSD
7.2.1 MSD Company Summary
7.2.2 MSD Business Overview
7.2.3 MSD Assisted Reproductive Technologies Medications Major Product Offerings
7.2.4 MSD Assisted Reproductive Technologies Medications Revenue in Global Market (2018-2023)
7.2.5 MSD Key News & Latest Developments
7.3 Ipsen
7.3.1 Ipsen Company Summary
7.3.2 Ipsen Business Overview
7.3.3 Ipsen Assisted Reproductive Technologies Medications Major Product Offerings
7.3.4 Ipsen Assisted Reproductive Technologies Medications Revenue in Global Market (2018-2023)
7.3.5 Ipsen Key News & Latest Developments
7.4 Ferring
7.4.1 Ferring Company Summary
7.4.2 Ferring Business Overview
7.4.3 Ferring Assisted Reproductive Technologies Medications Major Product Offerings
7.4.4 Ferring Assisted Reproductive Technologies Medications Revenue in Global Market (2018-2023)
7.4.5 Ferring Key News & Latest Developments
7.5 Organon
7.5.1 Organon Company Summary
7.5.2 Organon Business Overview
7.5.3 Organon Assisted Reproductive Technologies Medications Major Product Offerings
7.5.4 Organon Assisted Reproductive Technologies Medications Revenue in Global Market (2018-2023)
7.5.5 Organon Key News & Latest Developments
7.6 Solvay
7.6.1 Solvay Company Summary
7.6.2 Solvay Business Overview
7.6.3 Solvay Assisted Reproductive Technologies Medications Major Product Offerings
7.6.4 Solvay Assisted Reproductive Technologies Medications Revenue in Global Market (2018-2023)
7.6.5 Solvay Key News & Latest Developments
7.7 Besins
7.7.1 Besins Company Summary
7.7.2 Besins Business Overview
7.7.3 Besins Assisted Reproductive Technologies Medications Major Product Offerings
7.7.4 Besins Assisted Reproductive Technologies Medications Revenue in Global Market (2018-2023)
7.7.5 Besins Key News & Latest Developments
7.8 Zhejiang Xianju
7.8.1 Zhejiang Xianju Company Summary
7.8.2 Zhejiang Xianju Business Overview
7.8.3 Zhejiang Xianju Assisted Reproductive Technologies Medications Major Product Offerings
7.8.4 Zhejiang Xianju Assisted Reproductive Technologies Medications Revenue in Global Market (2018-2023)
7.8.5 Zhejiang Xianju Key News & Latest Developments
7.9 Changchun GeneScience
7.9.1 Changchun GeneScience Company Summary
7.9.2 Changchun GeneScience Business Overview
7.9.3 Changchun GeneScience Assisted Reproductive Technologies Medications Major Product Offerings
7.9.4 Changchun GeneScience Assisted Reproductive Technologies Medications Revenue in Global Market (2018-2023)
7.9.5 Changchun GeneScience Key News & Latest Developments
7.10 Hybio Pharmaceutical
7.10.1 Hybio Pharmaceutical Company Summary
7.10.2 Hybio Pharmaceutical Business Overview
7.10.3 Hybio Pharmaceutical Assisted Reproductive Technologies Medications Major Product Offerings
7.10.4 Hybio Pharmaceutical Assisted Reproductive Technologies Medications Revenue in Global Market (2018-2023)
7.10.5 Hybio Pharmaceutical Key News & Latest Developments
7.11 Livzon Pharmaceutical
7.11.1 Livzon Pharmaceutical Company Summary
7.11.2 Livzon Pharmaceutical Business Overview
7.11.3 Livzon Pharmaceutical Assisted Reproductive Technologies Medications Major Product Offerings
7.11.4 Livzon Pharmaceutical Assisted Reproductive Technologies Medications Revenue in Global Market (2018-2023)
7.11.5 Livzon Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Assisted Reproductive Technologies Medications Market Opportunities & Trends in Global Market
Table 2. Assisted Reproductive Technologies Medications Market Drivers in Global Market
Table 3. Assisted Reproductive Technologies Medications Market Restraints in Global Market
Table 4. Key Players of Assisted Reproductive Technologies Medications in Global Market
Table 5. Top Assisted Reproductive Technologies Medications Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Assisted Reproductive Technologies Medications Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Assisted Reproductive Technologies Medications Revenue Share by Companies, 2018-2023
Table 8. Global Companies Assisted Reproductive Technologies Medications Product Type
Table 9. List of Global Tier 1 Assisted Reproductive Technologies Medications Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Assisted Reproductive Technologies Medications Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Assisted Reproductive Technologies Medications Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Assisted Reproductive Technologies Medications Revenue in Global (US$, Mn), 2024-2032
Table 14. By Channel ? Global Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2022 & 2032
Table 15. By Channel - Assisted Reproductive Technologies Medications Revenue in Global (US$, Mn), 2018-2023
Table 16. By Channel - Assisted Reproductive Technologies Medications Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Assisted Reproductive Technologies Medications Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Assisted Reproductive Technologies Medications Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2024-2032
Table 30. Merck Company Summary
Table 31. Merck Assisted Reproductive Technologies Medications Product Offerings
Table 32. Merck Assisted Reproductive Technologies Medications Revenue (US$, Mn) & (2018-2023)
Table 33. Merck Key News & Latest Developments
Table 34. MSD Company Summary
Table 35. MSD Assisted Reproductive Technologies Medications Product Offerings
Table 36. MSD Assisted Reproductive Technologies Medications Revenue (US$, Mn) & (2018-2023)
Table 37. MSD Key News & Latest Developments
Table 38. Ipsen Company Summary
Table 39. Ipsen Assisted Reproductive Technologies Medications Product Offerings
Table 40. Ipsen Assisted Reproductive Technologies Medications Revenue (US$, Mn) & (2018-2023)
Table 41. Ipsen Key News & Latest Developments
Table 42. Ferring Company Summary
Table 43. Ferring Assisted Reproductive Technologies Medications Product Offerings
Table 44. Ferring Assisted Reproductive Technologies Medications Revenue (US$, Mn) & (2018-2023)
Table 45. Ferring Key News & Latest Developments
Table 46. Organon Company Summary
Table 47. Organon Assisted Reproductive Technologies Medications Product Offerings
Table 48. Organon Assisted Reproductive Technologies Medications Revenue (US$, Mn) & (2018-2023)
Table 49. Organon Key News & Latest Developments
Table 50. Solvay Company Summary
Table 51. Solvay Assisted Reproductive Technologies Medications Product Offerings
Table 52. Solvay Assisted Reproductive Technologies Medications Revenue (US$, Mn) & (2018-2023)
Table 53. Solvay Key News & Latest Developments
Table 54. Besins Company Summary
Table 55. Besins Assisted Reproductive Technologies Medications Product Offerings
Table 56. Besins Assisted Reproductive Technologies Medications Revenue (US$, Mn) & (2018-2023)
Table 57. Besins Key News & Latest Developments
Table 58. Zhejiang Xianju Company Summary
Table 59. Zhejiang Xianju Assisted Reproductive Technologies Medications Product Offerings
Table 60. Zhejiang Xianju Assisted Reproductive Technologies Medications Revenue (US$, Mn) & (2018-2023)
Table 61. Zhejiang Xianju Key News & Latest Developments
Table 62. Changchun GeneScience Company Summary
Table 63. Changchun GeneScience Assisted Reproductive Technologies Medications Product Offerings
Table 64. Changchun GeneScience Assisted Reproductive Technologies Medications Revenue (US$, Mn) & (2018-2023)
Table 65. Changchun GeneScience Key News & Latest Developments
Table 66. Hybio Pharmaceutical Company Summary
Table 67. Hybio Pharmaceutical Assisted Reproductive Technologies Medications Product Offerings
Table 68. Hybio Pharmaceutical Assisted Reproductive Technologies Medications Revenue (US$, Mn) & (2018-2023)
Table 69. Hybio Pharmaceutical Key News & Latest Developments
Table 70. Livzon Pharmaceutical Company Summary
Table 71. Livzon Pharmaceutical Assisted Reproductive Technologies Medications Product Offerings
Table 72. Livzon Pharmaceutical Assisted Reproductive Technologies Medications Revenue (US$, Mn) & (2018-2023)
Table 73. Livzon Pharmaceutical Key News & Latest Developments
List of Figures
Figure 1. Assisted Reproductive Technologies Medications Segment by Type in 2022
Figure 2. Assisted Reproductive Technologies Medications Segment by Channel in 2022
Figure 3. Global Assisted Reproductive Technologies Medications Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Assisted Reproductive Technologies Medications Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Assisted Reproductive Technologies Medications Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Assisted Reproductive Technologies Medications Revenue in 2022
Figure 8. By Type - Global Assisted Reproductive Technologies Medications Revenue Market Share, 2018-2032
Figure 9. By Channel - Global Assisted Reproductive Technologies Medications Revenue Market Share, 2018-2032
Figure 10. By Type - Global Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Assisted Reproductive Technologies Medications Revenue Market Share, 2018-2032
Figure 12. By Channel - Global Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Channel - Global Assisted Reproductive Technologies Medications Revenue Market Share, 2018-2032
Figure 14. By Region - Global Assisted Reproductive Technologies Medications Revenue Market Share, 2018-2032
Figure 15. By Country - North America Assisted Reproductive Technologies Medications Revenue Market Share, 2018-2032
Figure 16. US Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Assisted Reproductive Technologies Medications Revenue Market Share, 2018-2032
Figure 20. Germany Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2018-2032
Figure 21. France Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Assisted Reproductive Technologies Medications Revenue Market Share, 2018-2032
Figure 28. China Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2018-2032
Figure 32. India Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Assisted Reproductive Technologies Medications Revenue Market Share, 2018-2032
Figure 34. Brazil Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Assisted Reproductive Technologies Medications Revenue Market Share, 2018-2032
Figure 37. Turkey Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Assisted Reproductive Technologies Medications Revenue, (US$, Mn), 2018-2032
Figure 41. Merck Assisted Reproductive Technologies Medications Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. MSD Assisted Reproductive Technologies Medications Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Ipsen Assisted Reproductive Technologies Medications Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Ferring Assisted Reproductive Technologies Medications Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Organon Assisted Reproductive Technologies Medications Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Solvay Assisted Reproductive Technologies Medications Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Besins Assisted Reproductive Technologies Medications Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Zhejiang Xianju Assisted Reproductive Technologies Medications Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Changchun GeneScience Assisted Reproductive Technologies Medications Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Hybio Pharmaceutical Assisted Reproductive Technologies Medications Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Livzon Pharmaceutical Assisted Reproductive Technologies Medications Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
